Ibogaine company receives $15 million from Google co-founder’s nonprofit; Could a road through federal land derail a planned psilocybin center in Oregon?; questions remain about FDA’s investigation
Should neuroscience researchers embrace religion and spirituality? Washington psychedelics ballot initiative advances; and learning from pre-1970s psychedelics researchers